Ved administration af filgrastim til perifer blodstamcellemobilisering bør filgrastim seponeres eller dosis reduceres, hvis leukocyttallet stiger til > 70 x 109/ l.
However, during the period of administration of filgrastim for PBPC mobilisation, it should be discontinued or its dose should be reduced if the leukocyte counts rise to > 70 x 109/ l.